8-K//Current report
ADIAL PHARMACEUTICALS, INC. 8-K
Accession 0001213900-25-070671
$ADILCIK 0001513525operating
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:51 PM ET
Size
541.2 KB
Accession
0001213900-25-070671
Documents
- 8-Kea0251183-8k_adial.htmPrimary
CURRENT REPORT
- EX-1.1ea025118301ex1-1_adial.htm
SALES AGREEMENT, DATED AUGUST 1, 2025, ENTERED INTO BY AND BETWEEN ADIAL PHARMACEUTICALS, INC. AND A.G.P./ALLIANCE GLOBAL PARTNERS
- EX-5.1ea025118301ex5-1_adial.htm
OPINION OF BLANK ROME LLP
- GRAPHICex5-1_001.jpg
GRAPHIC
- EX-101.SCHadil-20250731.xsd
XBRL SCHEMA FILE
- EX-101.LABadil-20250731_lab.xml
XBRL LABEL FILE
- EX-101.PREadil-20250731_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-070671-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0251183-8k_adial_htm.xml
IDEA: XBRL DOCUMENT
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001513525
Filing Metadata
- Form type
- 8-K
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 4:51 PM ET
- Size
- 541.2 KB